Investor profile
3B Future Health Fund has backed 6 European tech companies across 6 funding rounds between 2022 and 2024, joining rounds totalling €205M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| iOnctura | Switzerland | 1 | €80M |
| Domain Therapeutics | France | 1 | €40M |
| Epsilogen | UK | 1 | €37M |
| Sibylla Biotech | Italy | 1 | €23M |
| Kither Biotech | Italy |
| Company | Stage | Amount | Date |
|---|---|---|---|
| iOnctura | Series B | €80M | 2024-06 |
| Domain Therapeutics | Series A | €40M | 2022-05 |
| Epsilogen | Series B | €37M | 2022-03 |
| Sibylla Biotech |
| 1 |
| €19M |
| NeoPhore | UK | 1 | €6.8M |
| Series A |
| €23M |
| 2022-10 |
| Kither Biotech | Series B | €19M | 2022-03 |
| NeoPhore | Series B | €6.8M | 2023-01 |
